HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,513-1,524 of 4,505
Other study type icon
CompletedNCT01875822

Study of Curcumin C-3 Complex in Schizophrenia

Official study title

Open Label Study of Curcumin C-3 Complex, the Prototypal Epigenetic Modulator, as an Augmentation Strategy to Antipsychotic Therapy,for Improving Negative Symptoms and Cognition in Schizophrenia

This study has finished and is no longer accepting participants.

In San Juan
Schizophrenia, DepressionInterventional studyAges 18–65
Countries
United States
Sponsor
Woodbury, Michel, M.D.
Drug study icon
CompletedNCT01752712

Oxytocin and CBSST for People With Schizophrenia

Official study title

Combined Oxytocin and CBSST for Social Function in People With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including San Diego
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
University of Maryland, Baltimore
Drug study icon
CompletedNCT01028677

Oxytocin Treatment of Schizophrenia

Official study title

Oxytocin Treatment of Social Deficits and Paranoia in Schizophrenia

This study has finished and is no longer accepting participants.

In Chapel Hill
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Drug study icon
WithdrawnNCT05974527

Sublingual Dexmedetomidine for Schizophrenia

Official study title

Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department

This study was withdrawn before enrollment.

Location not clearly listed
Schizophrenia, BipolarityMedication studyAges 18+
Countries
Sponsor
Brigham and Women's Hospital
Drug study icon
CompletedNCT00918021

Polypharmacy in Clozapine-resistant Schizophrenia

Official study title

Olanzapine Augmentation in Clozapine-resistant Schizophrenia: a Randomized Double-blind Study

This study has finished and is no longer accepting participants.

In Kuopio
SchizophreniaMedication studyAges 18+
Countries
Finland
Sponsor
Niuvanniemi Hospital

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.